Salidroside is the primary active ingredient of Rhodiola and can alleviate insulin resistance, hyperglycemia, and liver inflammation in db/db mice by inhibiting the HMGB1/RAGE/NF-κB and HMGB1/TLR4/NLRP3 signaling pathways (107). This evidence concerns the gene TLR4 and Insulin resistance.